Aurobindo Pharma working on COVID-19 vaccine

August 07, 2020 11:47

Aurobindo Pharma Limited is working on developing several viral vaccines including one for COVID-19 even as the candidate was approved for funding by the Department of BioTechnology, the company said in its latest annual report.

During the year (FY20), we have further strengthened our presence in the vaccines segment through the acquisition of R&D assets from Profectus Biosciences through Auro Vaccines. Using those R&D assets, the team is working on developing several viral vaccines, including a vaccine for COVID-19," it said.

In November 2019, Aurobindo Pharma said its subsidiary Auro Vaccines LLC entered into a pact to acquire certain business assets from Profectus BioSciences Inc USA for an upfront cash consideration of USD 11.29 million (around Rs 80 crore) with potential earn-outs on achieving certain milestones. -- PTI

« Back to LIVE

TOP STORIES

IPL PIX: Clinical KKR outclass MI; inch closer to play-offs!

Kolkata Knight Riders outclassed Mumbai Indians by 24 runs in the IPL 2024 match on Friday.

Canadian police arrest 3 suspects in Nijjar murder case: Media report

Three people have been arrested and charged in the killing of Sikh activist Nijjar, CTV News quoted a senior government source as saying.

Rohith Vemula not a Dalit, he ended life because....: Police closure report

The Cyberabad police that investigated the case informed the court that Rohith Vemula did not belong to Scheduled Caste and that he was aware of it.

Kin seek CBI probe into death of Salman home shooting accused

He had allegedly hanged himself with a bed sheet in the toilet of the lock-up, as per the police.

7 Adani group firms have received Sebi show cause notices

Seven out of the 10 listed firms of Adani group have received show cause notices from the Securities and Exchange Board of India (Sebi) for alleged violation of related party transactions and non-compliance with listing regulations, the...